Wadakohsan Corporation
Wadakohsan Corporation (8931.T) Financial Performance & Income Statement Overview
Explore the financials of Wadakohsan Corporation (8931.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Wadakohsan Corporation (8931.T) Income Statement & Financial Overview
Explore comprehensive income reports for Wadakohsan Corporation 8931.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.38B | $13.60B | $9.17B | $10.98B |
| Cost of Revenue | $4.71B | $9.99B | $7.07B | $8.61B |
| Gross Profit | $1.67B | $3.61B | $2.10B | $2.37B |
| Gross Profit Ratio | $0.26 | $0.27 | $0.23 | $0.22 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.05B | $1.13B | $1.17B | $1.12B |
| Operating Expenses | $1.05B | $1.13B | $1.17B | $1.12B |
| Total Costs & Expenses | $5.76B | $11.11B | $8.25B | $9.73B |
| Interest Income | $6.54M | $0.00 | $3.71M | $67000.00 |
| Interest Expense | $0.00 | $0.00 | $179.71M | $171.85M |
| Depreciation & Amortization | $189.004M | $170.25M | $73.49M | $171.56M |
| EBITDA | $814.19M | $2.65B | $996.94M | $1.17B |
| EBITDA Ratio | $0.13 | $0.20 | $0.11 | $0.11 |
| Operating Income | $625.19M | $2.48B | $923.45M | $1.25B |
| Operating Income Ratio | $0.10 | $0.18 | $0.10 | $0.11 |
| Other Income/Expenses (Net) | -$214.97M | -$215.70M | -$106.22M | -$253.61M |
| Income Before Tax | $410.22M | $2.27B | $817.23M | $999.25M |
| Income Before Tax Ratio | $0.06 | $0.17 | $0.09 | $0.09 |
| Income Tax Expense | $101.91M | $697.009M | $260.98M | $313.20M |
| Net Income | $308.31M | $1.57B | $556.25M | $686.05M |
| Net Income Ratio | $0.05 | $0.12 | $0.06 | $0.06 |
| EPS | $28.24 | $143.48 | $50.75 | $62.20 |
| Diluted EPS | $28.24 | $143.48 | $50.75 | $62.20 |
| Weighted Avg Shares Outstanding | $10.92M | $10.96M | $10.96M | $11.03M |
| Weighted Avg Shares Outstanding (Diluted) | $10.92M | $10.96M | $10.96M | $11.03M |
Over the last four quarters, Wadakohsan Corporation's revenue moved from $10.98B in Q1 2024 to $6.38B in Q4 2024. Operating income in Q4 2024 was $625.19M, with a strong operating margin of 10%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Wadakohsan Corporation remained robust at $814.19M, reflecting operational efficiency. Net income dropped to $308.31M, with an EPS of $28.24. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan